This Viewpoint advocates for all US residents, regardless of immigration status, to be included in plans for a universal health care system.
This essay examines groups that are underrepresented in the medical workforce, how the COVID-19 pandemic may affect these groups, and suggests strategies for addressing these issues.
This Viewpoint describes benefits and harms of using machine learning algorithms with regard to diagnostic errors, race and ethnicity, and health disparities in the US.
This Viewpoint confronts the anti-Asian racism and health disparities that have been revealed during the challenges of the COVID-19 pandemic.
This cohort study uses commercial claims data to assess whether increased patient cost sharing is associated with the likelihood of early, uncomplicated presentation or surgical management of emergency general surgery diagnoses.
This cross-sectional study uses a large Medicare data set of older adults with low back pain to examine how race and ethnicity may have been associated with opioid prescribing by primary care physicians during the first wave of the opioid epidemic.
This cohort study examines the 5-year association of Medicaid expansion with uninsurance rates and hypertension and diabetes outcome measures by race and ethnicity in federally qualified health centers.
This cross-sectional study seeks to determine how health insurance coverage changed in the US during the COVID-19 pandemic.
This cohort study examines the association between Medicaid home care services and family caregivers’ health using data from the 1996 to 2017 Medical Expenditures Panel Survey.
This decision analytical model investigates associations between a federal regulation requiring graphic health warnings on cigarette packaging in the US and changes in estimates of smoking-attributable deaths and life-years gained based on implementation dates of 2012 vs 2022.
This cross-sectional study evaluates neighborhood-level data in the 9 largest US cities to identify inequities in COVID-19 vaccination rates.
This study examines whether becoming eligible for Medicare is associated with less out-of-pocket health care spending and lower catastrophic health care expenditure risk.
This cross-sectional study describes changes in annual Medicare Part B spending for biologic drugs after biosimilar entry, focusing on the first 4 products to experience biosimilar competition: filgrastim, infliximab, epoetin alpha, and pegfilgrastim.
This cohort study examines the alignment of vaccination and SARS-CoV-2 risk in Massachusetts by creating and applying a vaccination-to-infection risk ratio.
This cross-sectional regression discontinuity analysis compares deaths slightly younger and older than 65 years to examine the relationship between access to health insurance coverage and COVID-19 mortality.
This Special Communication provides a legal analysis of whether the First Amendment prohibits the US Food and Drug Administration’s requirement of new tobacco warning labels.